Senators cite study showing 22 times higher serious side effects from chemical abortion drugs than FDA labels indicate, ...
In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...
Under FDA regulations, suspension is not the end of the process. Unless a license holder voluntarily relinquishes its license ...
The US Food and Drug Administration is reviewing evidence about the safety and efficacy of mifepristone, one of the drugs ...
The Food and Drug Administration’s recent approval of a second generic version of the abortion pill mifepristone has left ...
The U.S. Food and Drug Administration (FDA) has approved two new biosimilars as reference products for Prolia (denosumab) and ...
The Food and Drug Administration is reviewing the safety of the abortion pill mifepristone, Health and Human Services Secretary Robert F. Kennedy Jr. said in a recent letter to Republican state ...
The U.S. Food and Drug Administration is changing its policy on who should get COVID-19 shots, potentially limiting access to new vaccine formulations as they enter the market. New and updated jabs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback